Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification
Zhu, Dongxing and Hadoke, Patrick W.F. and Wu, Junxi and Vesey, Alex T. and Lerman, Daniel A. and Dweck, Marc R. and Newby, David E. and Smith, Lee B. and MacRae, Vicky E. (2016) Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Scientific Reports, 6. 24807. ISSN 2045-2322 (https://doi.org/10.1038/srep24807)
Preview |
Text.
Filename: Zhu_etal_SR2016_Ablation_androgen_receptor_vascular_smooth_muscle_cells_demonstrates_role_testosterone_vascular_calcification.pdf
Final Published Version License: Download (2MB)| Preview |
Abstract
Vascular calcification powerfully predicts mortality and morbidity from cardiovascular disease. Men have a greater risk of cardiovascular disease, compared to women of a similar age. These gender disparities suggest an influence of sex hormones. Testosterone is the primary and most well-recognised androgen in men. Therefore, we addressed the hypothesis that exogenous androgen treatment induces vascular calcification. Immunohistochemical analysis revealed expression of androgen receptor (AR) in the calcified media of human femoral artery tissue and calcified human valves. Furthermore, in vitro studies revealed increased phosphate (Pi)-induced mouse vascular smooth muscle cell (VSMC) calcification following either testosterone or dihydrotestosterone (DHT) treatment for 9 days. Testosterone and DHT treatment increased tissue non-specific alkaline phosphatase (Alpl) mRNA expression. Testosterone-induced calcification was blunted in VSMC-specific AR-ablated (SM-ARKO) VSMCs compared to WT. Consistent with these data, SM-ARKO VSMCs showed a reduction in Osterix mRNA expression. However, intriguingly, a counter-intuitive increase in Alpl was observed. These novel data demonstrate that androgens play a role in inducing vascular calcification through the AR. Androgen signalling may represent a novel potential therapeutic target for clinical intervention.
ORCID iDs
Zhu, Dongxing, Hadoke, Patrick W.F., Wu, Junxi ORCID: https://orcid.org/0000-0002-1334-887X, Vesey, Alex T., Lerman, Daniel A., Dweck, Marc R., Newby, David E., Smith, Lee B. and MacRae, Vicky E.;-
-
Item type: Article ID code: 72901 Dates: DateEvent20 April 2016Published5 April 2016AcceptedSubjects: Medicine
Technology > Engineering (General). Civil engineering (General) > BioengineeringDepartment: Faculty of Engineering > Biomedical Engineering
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical SciencesDepositing user: Pure Administrator Date deposited: 25 Jun 2020 08:36 Last modified: 11 Nov 2024 12:42 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/72901